US5849263A
(en)
*
|
1993-03-30 |
1998-12-15 |
Charlotte-Mecklenburg Hospital Authority |
Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
|
CA2213638C
(en)
*
|
1995-02-24 |
2004-05-04 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
US6517860B1
(en)
*
|
1996-12-31 |
2003-02-11 |
Quadrant Holdings Cambridge, Ltd. |
Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
NZ511442A
(en)
*
|
1998-11-02 |
2003-02-28 |
Elan Corp Plc |
Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
DE60013773T2
(de)
|
1999-02-03 |
2005-11-10 |
Biosante Pharmaceuticals, Inc. |
Methoden zur Herstellung von therapeutischen Kalziumphosphat Partikeln
|
US20040258763A1
(en)
*
|
1999-02-03 |
2004-12-23 |
Bell Steve J.D. |
Methods of manufacture and use of calcium phosphate particles containing allergens
|
US20020054914A1
(en)
*
|
1999-02-03 |
2002-05-09 |
Tulin Morcol |
Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
|
US6270806B1
(en)
|
1999-03-03 |
2001-08-07 |
Elan Pharma International Limited |
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
|
US7919119B2
(en)
*
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US20030096798A1
(en)
*
|
1999-11-09 |
2003-05-22 |
Williams Gordon H. |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
US20030203884A1
(en)
*
|
1999-11-09 |
2003-10-30 |
Pharmacia Corporation |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
EP1175434A2
(de)
*
|
1999-12-08 |
2002-01-30 |
Pharmacia Corporation |
Kristalline form von eplerenon
|
WO2001041760A2
(en)
*
|
1999-12-08 |
2001-06-14 |
Pharmacia Corporation |
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
GB0009773D0
(en)
|
2000-04-19 |
2000-06-07 |
Univ Cardiff |
Particulate composition
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
ES2525087T5
(es)
*
|
2000-05-10 |
2018-06-28 |
Novartis Ag |
Polvos basados en fosfolípidos para administración de fármacos
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
JP2004503601A
(ja)
*
|
2000-07-13 |
2004-02-05 |
ファルマシア・コーポレーション |
眼のcox−2媒介疾患の処置及び予防におけるcox−2阻害剤の使用法
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
ES2265437T3
(es)
*
|
2000-07-27 |
2007-02-16 |
Pharmacia Corporation |
Terapia de combinacion antagonista epoxi-esteroidal de aldosterona y antagonista beta-adrenergico para tratamiento de la insuficiencia cardiaca congestiva.
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
US20020111337A1
(en)
*
|
2000-08-28 |
2002-08-15 |
Fedde Kenton N. |
Use of an aldosterone receptor antagonist to improve cognitive function
|
US20060177416A1
(en)
*
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
EP1313451B1
(de)
|
2000-08-31 |
2009-03-11 |
Jagotec AG |
Gemahlene partikel
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20040033267A1
(en)
*
|
2002-03-20 |
2004-02-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
PL199420B1
(pl)
*
|
2000-10-09 |
2008-09-30 |
3M Innovative Properties Co |
Medyczne preparaty aerozolowe
|
US20040081627A1
(en)
*
|
2000-10-09 |
2004-04-29 |
Jinks Phillip A |
Medicinal aerosol formulations
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US7766013B2
(en)
*
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
DE60203506T2
(de)
*
|
2001-06-22 |
2006-02-16 |
Marie Lindner |
Screening-verfahren mit hohem durchsatz (hts) unter verwendung von labormühlen oder microfluidics
|
US20030220310A1
(en)
*
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
US20030185892A1
(en)
*
|
2001-08-17 |
2003-10-02 |
Bell Steve J. D. |
Intraocular delivery compositions and methods
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
CA2460867C
(en)
*
|
2001-09-19 |
2011-04-12 |
Elan Pharma International Ltd. |
Nanoparticulate insulin formulations
|
WO2003026662A1
(en)
*
|
2001-09-25 |
2003-04-03 |
Pharmacia Corporation |
Solid-state forms of n-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole
|
CA2463495C
(en)
*
|
2001-10-12 |
2011-05-24 |
Elan Pharma International Ltd. |
Compositions having a combination of immediate release and controlled release characteristics
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
CA2475092C
(en)
*
|
2002-02-04 |
2012-05-01 |
Christian F. Wertz |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
WO2003080023A2
(en)
*
|
2002-03-20 |
2003-10-02 |
Elan Pharma International Limited |
Fast dissolving dosage forms having reduced friability
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
AU2003230885A1
(en)
|
2002-04-12 |
2003-10-27 |
Elan Pharma International Ltd. |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
AU2003234452A1
(en)
*
|
2002-05-06 |
2003-11-11 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7763278B2
(en)
*
|
2002-06-10 |
2010-07-27 |
Elan Pharma International Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
JP4776229B2
(ja)
*
|
2002-07-16 |
2011-09-21 |
エラン ファーマ インターナショナル,リミティド |
安定なナノ粒子活性物質の液体投与組成物
|
US20030017208A1
(en)
*
|
2002-07-19 |
2003-01-23 |
Francis Ignatious |
Electrospun pharmaceutical compositions
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
CA2500908A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
US20040156895A1
(en)
*
|
2002-11-12 |
2004-08-12 |
Elan Pharma International Ltd. |
Solid dosage forms comprising pullulan
|
US20040105818A1
(en)
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
US20040173696A1
(en)
*
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
US7390505B2
(en)
*
|
2003-01-31 |
2008-06-24 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
JP5137228B2
(ja)
*
|
2003-03-07 |
2013-02-06 |
メルク・シャープ・アンド・ドーム・コーポレーション |
高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用
|
ATE418551T1
(de)
|
2003-03-07 |
2009-01-15 |
Schering Corp |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
WO2004104491A2
(en)
|
2003-05-21 |
2004-12-02 |
Alexza Pharmaceuticals, Inc. |
Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
|
US7842232B2
(en)
*
|
2003-05-22 |
2010-11-30 |
Elan Pharma International, Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
CA2534924A1
(en)
*
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel metaxalone compositions
|
BRPI0415403A
(pt)
*
|
2003-10-15 |
2006-12-05 |
Pari Gmbh |
preparação lìquida contendo tobramicina
|
US7879360B2
(en)
*
|
2003-11-05 |
2011-02-01 |
Elan Pharma International, Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
AU2005219372A1
(en)
*
|
2004-02-13 |
2005-09-15 |
Safeway Investments Ltd. |
Therapeutic calcium phosphate particles and methods of making and using same
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
CA2586035A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
|
US7910577B2
(en)
*
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
CN1301747C
(zh)
*
|
2004-11-30 |
2007-02-28 |
深圳市海王英特龙生物技术股份有限公司 |
一种蛋白药物微囊及其吸入性气雾剂
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
EP1835889A1
(de)
*
|
2004-12-15 |
2007-09-26 |
Elan Pharma International Limited |
Nanoteilchenförmige tacrolimus-formulierungen
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
CA2594332A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
EP2332524A1
(de)
|
2005-02-15 |
2011-06-15 |
Elan Pharma International Limited |
Aerosol und injizierbare Formulierung mit nanopartikulärem Benzodiazepin
|
US20080254114A1
(en)
*
|
2005-03-03 |
2008-10-16 |
Elan Corporation Plc |
Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
|
WO2006099121A2
(en)
*
|
2005-03-10 |
2006-09-21 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
|
BRPI0606283A2
(pt)
*
|
2005-03-16 |
2009-06-09 |
Elan Pharma Int Ltd |
formulações de antagonista de receptor de leucotrieno/corticosteróide em nanopartìcula
|
JP2008533173A
(ja)
*
|
2005-03-17 |
2008-08-21 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子ビスホスホネート組成物
|
US8003127B2
(en)
*
|
2005-03-23 |
2011-08-23 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof
|
CN101171000A
(zh)
*
|
2005-04-12 |
2008-04-30 |
依兰药物国际有限公司 |
包含环孢菌素的毫微粒和控制释放组合物
|
US8309133B2
(en)
*
|
2005-04-12 |
2012-11-13 |
Alkermes Pharma Ireland Limited |
Nanoparticulate quinazoline derivative formulations
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
WO2006132752A1
(en)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
KR20080008403A
(ko)
*
|
2005-05-10 |
2008-01-23 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 클로피도그렐 제제
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
CN101262860A
(zh)
*
|
2005-06-03 |
2008-09-10 |
伊兰制药国际有限公司 |
纳米微粒对乙酰氨基酚制剂
|
JP2008542397A
(ja)
*
|
2005-06-03 |
2008-11-27 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子メシル酸イマチニブ製剤
|
US20070042049A1
(en)
*
|
2005-06-03 |
2007-02-22 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
JP2009517485A
(ja)
|
2005-06-08 |
2009-04-30 |
エラン・ファルマ・インターナショナル・リミテッド |
セフジトレンを含むナノ粒子状および制御放出組成物
|
CA2611475A1
(en)
*
|
2005-06-09 |
2006-12-21 |
Elan Pharma International, Limited |
Nanoparticulate ebastine formulations
|
MX2007015882A
(es)
*
|
2005-06-13 |
2008-03-04 |
Elan Pharma Int Ltd |
Formulaciones en combinacion nanoparticulada de clopidogrel y aspirina.
|
WO2006138421A2
(en)
*
|
2005-06-15 |
2006-12-28 |
Elan Pharma International Limited |
Nanoparticulate azelnidipine formulations
|
WO2007008537A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
CA2614409C
(en)
*
|
2005-07-07 |
2014-05-20 |
Nanotherapeutics, Inc |
Process for milling and preparing powders and compositions produced thereby
|
US20070104792A1
(en)
*
|
2005-09-13 |
2007-05-10 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
JP2009508859A
(ja)
|
2005-09-15 |
2009-03-05 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アリピプラゾール製剤
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
CA2653504A1
(en)
*
|
2006-05-30 |
2007-12-13 |
Elan Pharma International Ltd. |
Nanoparticulate posaconazole formulations
|
EP2049084A2
(de)
*
|
2006-07-10 |
2009-04-22 |
Elan Pharma International Limited |
Nanoteilchenförmige sorafenib-formulierungen
|
KR20090031618A
(ko)
*
|
2006-07-12 |
2009-03-26 |
엘란 코포레이션, 피엘씨 |
나노입자형 모다피닐 제제
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
US20080216828A1
(en)
|
2007-03-09 |
2008-09-11 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
WO2009117401A2
(en)
*
|
2008-03-21 |
2009-09-24 |
Elan Pharama International Limited |
Compositions for site-specific delivery of imatinib and methods of use
|
WO2009156706A1
(en)
*
|
2008-06-27 |
2009-12-30 |
University Of Strathclyde |
Pulmonary drug delivery with vesicles comprising non-ionic surfactants
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
CN102458380A
(zh)
*
|
2009-04-24 |
2012-05-16 |
先灵公司 |
包含具有目的颗粒大小的活性药物试剂的团聚体制剂
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
WO2010138539A2
(en)
|
2009-05-27 |
2010-12-02 |
Elan Pharma International Ltd. |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
US20110236769A1
(en)
*
|
2010-03-23 |
2011-09-29 |
Xing Xie |
Three dimensional electrodes useful for microbial fuel cells
|
JP5567215B2
(ja)
*
|
2010-09-20 |
2014-08-06 |
ロレアル |
アルキルセルロースを含む水性化粧品組成物
|
WO2013016156A1
(en)
|
2011-07-22 |
2013-01-31 |
Glaxo Group Limited |
Polymorphic forms of the sodium salt of 4-tert- butyl -n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
|
RU2607515C2
(ru)
|
2011-07-22 |
2017-01-10 |
Хемоцентрикс, Инк. |
Кристаллическая форма натриевой соли 4-трет-бутил-n-{ 4-хлор-2-(1-окси-пиридин-4-карбонил)-фенил} -бензолсульфонамид
|
WO2013030374A1
(en)
|
2011-09-01 |
2013-03-07 |
Glaxo Group Limited |
Novel crystal form
|
WO2015198229A1
(en)
|
2014-06-25 |
2015-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
|
WO2016038519A1
(en)
|
2014-09-08 |
2016-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
TWI773641B
(zh)
*
|
2015-05-08 |
2022-08-11 |
日商活效製藥股份有限公司 |
含有糖皮質類固醇(glucocorticoids)之奈米微粒子之水性懸浮液劑
|
CN108366942B
(zh)
|
2015-12-21 |
2022-01-14 |
莱雅公司 |
包含烷基纤维素、不相容的烃和硅油的组合物及其使用方法
|